[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353439-105":59,"doc-detail-353439-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","multifaceted-roles-of-cd44-in-cancer-progression-and-targeted-therapeutic-strategies","Multifaceted roles of CD44 in cancer progression and targeted therapeutic strategies","","CD44 is a multifunctional transmembrane glycoprotein that acts as a key driver of cancer progression rather than a passive marker. The review explains how its structural diversity—shaped by alternative splicing and post-translational cleavage and phosphorylation—supports cancer stem cell maintenance, metastasis, and therapy resistance. It also covers CD44 as a multivalent adhesion receptor for extracellular matrix ligands and as a co-receptor for receptor tyrosine kinases, emphasizing therapeutic strategies including antibodies, ADCs, peptide inhibitors, and CAR-T cells.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multifaceted-roles-of-cd44-in-cancer-progression-and-targeted-therapeutic-strategies/353439/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multifaceted-roles-of-cd44-in-cancer-progression-and-targeted-therapeutic-strategies/353439.png","ImageObject",300,407,{"name":92,"@type":93},"acoobca","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-19","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What makes CD44 important in cancer progression?","Question",{"text":113,"@type":114},"CD44 is described as a crucial driver of progression by promoting cancer stem cell maintenance, metastasis, and resistance to therapy in advanced malignancies.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does CD44 structural diversity arise?",{"text":118,"@type":114},"Its diversity is attributed to alternative splicing as well as post-translational modifications, including cleavage and phosphorylation.",{"name":120,"@type":111,"acceptedAnswer":121},"What therapeutic approaches targeting CD44 are discussed?",{"text":122,"@type":114},"The review highlights applications of unconjugated antibodies, antibody–drug conjugates, peptide-based inhibitors, and CAR-T cell therapies, and also addresses limitations from clinical studies.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},353439,1790213423,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3985747870733,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","[www.nature.com/emm](www.nature.com/emm)  \nREVIEW ARTICLE OPEN   \nMultifaceted roles of CD44 in cancer progression and targeted therapeutic strategies  \nHyun-Ji Oh1,3, Seung-Tae Kim1,3, Hyun-Jin Kim1, Kang-To Lee1 and Hyungshin Yim 1,2 ✉  \n© The Author(s) 2026  \n|  |  |  |\n| --- | --- | --- |\n|  | CD44, a multifunctional transmembrane glycoprotein, is not only a bystander but also a crucial driver of cancer progression that promotes cancer stem cell maintenance, metastasis, and resistance to therapy. Therefore, CD44 is recognized as a promising therapeutic target in advanced malignancies. Here, we discuss its unique features, such as its structural diversity, which arise from alternative splicing and the post-translational modiﬁcations of cleavage and phosphorylation. In addition, we discuss the function of CD44 as a multivalent cell adhesion receptor for extracellular matrix components, including hyaluronic acid, ﬁbronectin, osteopontin, and TSG6, thereby regulating lymphocyte activation, cell–cell interactions, cell adhesion, and migration within the extracellular matrix. Moreover, the emerging role of CD44 as a co-receptor of receptor tyrosine kinases such as epidermal growth factor receptor, c-MET, and vascular endothelial growth factor receptor 2 is highlighted to elucidate the contribution of CD44 to malignant signaling networks. We also discuss its potential as a therapeutic target in advanced cancers, particularly its applications in unconjugated antibodies, antibody–drug conjugates, peptide-based inhibitors, and chimeric antigen receptor-T cell therapies. We conclude by addressing the limitations observed in clinical studies and outlining promising opportunities for future |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| development. |  |  |\n|  | Experimental & Molecular Medicine (2026) 58:2451–2469; [https://doi.org/10.1038/s12276-026-01797-x](https://doi.org/10.1038/s12276-026-01797-x) |  |\n|  |  |  |\n\nINTRODUCTION  \nCD44 is a transmembrane glycoprotein that functions as a coreceptor of several growth factors and cytokines. It is also known as phagocytic glycoprotein-1 in murine mesenchymal cells1, class III collagen receptor in human ﬁbroblasts2–4, hermes antigen inhuman lymphocytes5, lymphocyte homing receptor6, and homing-associated cell adhesion molecule in human hematopoietic progenitors7. It has been identiﬁed as a multiple cell adhesion receptor for the extracellular matrix (ECM) components such ashyaluronic acid (HA)8, collagen3,4, ﬁbronectin3, osteopontin9, and tumor necrosis factor-stimulated gene 6 (TSG6)10 and involved in lymphocyte activation5, cell–cell interactions5, cell adhesion3, and migration in the ECM.  \nCD44 has been studied as a cancer stem cell (CSC) marker in breast cancer, colorectal cancer, and other cancers11, 12. Because of its high expression in several cancers, especially in advanced stages, it has been recognized as an important therapeutic target and biomarker for advanced cancer13. CD44 exists as a standard version and several variants formed through alternative splicing that have different expressions and functions in different tissues13. Owing to its extensive post-translational modiﬁcation, complex structures, and diverse functions, it has been studied in the context of major diseases, especially cancer. Here, we discuss the importance of CD44 as a therapeutic target for cancer treatment, along with ways that its function depends on post-translational modiﬁcations. The cleaved CD44-mediated signaling pathway in cancer and current clinical trials using CD44 as a therapeutic target will also be discussed.  \nSTRUCTURAL DIVERSITY OF CD44 AND ITS BIOLOGICAL FUNCTIONS  \nDiverse structure of CD44 and its isoforms via alternative splicing  \nCD44 is a type I transmembrane protein that consists of an extracellular domain (ECD, 248 amino acids), a transmembrane domain (TMD) (21 amino acids), and a cytoplasmic int","cbCaivFffox1tx3a","https://ap.wps.com/l/cbCaivFffox1tx3a","pdf",3955193,"English","# Introduction\n# Structural diversity of CD44 and its biological functions\n## Diverse structure of CD44 and its isoforms via alternative splicing","[{\"question\":\"What makes CD44 important in cancer progression?\",\"answer\":\"CD44 is described as a crucial driver of progression by promoting cancer stem cell maintenance, metastasis, and resistance to therapy in advanced malignancies.\"},{\"question\":\"How does CD44 structural diversity arise?\",\"answer\":\"Its diversity is attributed to alternative splicing as well as post-translational modifications, including cleavage and phosphorylation.\"},{\"question\":\"What therapeutic approaches targeting CD44 are discussed?\",\"answer\":\"The review highlights applications of unconjugated antibodies, antibody–drug conjugates, peptide-based inhibitors, and CAR-T cell therapies, and also addresses limitations from clinical studies.\"}]","Multifaceted roles of CD44 in cancer progression and targeted therapeutic strategies | PDF",1790105396,48,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d9cace67813b3d31a5ecf7bd69e78adf.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5fe3b5d8b75355830700113f13d8635c.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/658f4aa55108bf54a4746787ccf8649d.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c0ffc353d081ad9383f880d6a764aeb5.webp",980,1301]